Risk Factors of Mortality for Patients Receiving Venovenous Extracorporeal Membrane Oxygenation for COVID-19 Acute Respiratory Distress Syndrome.

导出 LinkOut

翻译打印收藏纠错

作者： Zachary R,Bergman ^[1] ; Jillian K,Wothe ^[2] ; Fatima S,Alwan ^[2] ; Arianna E,Lofrano ^[3] ; Kelly M,Tointon ^[4] ; Melissa,Doucette ^[4] ; John K,Bohman ^[5] ; Ramiro,Saavedra-Romero ^[4] ; Matthew E,Prekker ^[6] ; Elizabeth R,Lusczek ^[3] ; Greg,Beilman ^[1] ; Melissa E,Brunsvold ^[1]

作者单位： Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA. ^[1] University of Minnesota Medical School, University of Minnesota, Minneapolis, Minnesota, USA. ^[2] Department of Internal Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA. ^[3] Department of Critical Care Medicine, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. ^[4] Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. ^[5] Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA. ^[6]

关键词 ARDS COVID-19 ECMO mortality venovenous

主题词体外膜氧合作用(Extracorporeal Membrane Oxygenation);人类(Humans);回顾性研究(Retrospective Studies);危险因素(Risk Factors)

DOI 10.1089/sur.2021.114

PMID 34494893

发布时间 2021-12-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交